Dr. Naoshige Uchida's lab at Harvard University studies the neural circuits that control dopamine neuron activity, which is important for regulating behavior, motivation, and mood. Their research focuses on how different signals are processed in the brain's reward pathways and aims to uncover the mechanisms behind dopamine-related disorders like addiction and depression. By using advanced techniques, the lab investigates how neurons communicate and how learning influences these processes.

Dr. Sean R. Eddy's lab focuses on developing computational tools to analyze biological sequences and RNA structures. Their work is crucial for understanding evolutionary relationships among different life forms by leveraging large-scale genomic data. The lab's primary tools, HMMER and Infernal, help scientists find homologs of sequences more effectively, contributing to advancements in molecular biology and bioinformatics.

Dr. Florian Engert's lab at Harvard University studies how the brain and body interact, particularly focusing on zebrafish as a model organism. They aim to understand how animals perceive their environment and regulate their behaviors through neural circuits that are influenced by internal states like hunger and motivation. The lab investigates the genetic and neural mechanisms behind social behaviors, such as schooling and shoaling, using advanced imaging and modeling techniques.

Dr. Gokhan Hotamisligil's research focuses on understanding the role of a newly identified hormone complex named Fabkin in the context of atherosclerosis, a leading cause of cardiovascular diseases. The lab investigates how this complex influences lipid metabolism and inflammation, aiming to discover novel therapeutic strategies to improve current treatments for these conditions. Through animal studies and cellular experiments, the team seeks to unravel the mechanisms behind dyslipidemia and its contribution to heart disease.

Dr. Sarah Fortune's lab focuses on understanding how the bacterium Mycobacterium tuberculosis (Mtb) develops resilience to antibiotics, leading to treatment failures. The team investigates the genetic and molecular mechanisms that allow Mtb to survive antibiotic exposure and recover more effectively than usual. Ultimately, the lab aims to inform better treatment strategies for tuberculosis and enhance public health outcomes.

Dr. Wendy S. Garrett's lab at Harvard University focuses on understanding the role of the gut microbiome, particularly the bacterium Fusobacterium nucleatum, in colorectal cancer (CRC). The team investigates how specific bacterial activities contribute to CRC progression, response to therapy, and overall cancer susceptibility. By exploring the interactions between F. nucleatum and immune cells, the lab aims to uncover mechanisms that may apply to various cancers beyond CRC.

Dr. Rachelle Gaudet's lab at Harvard University studies membrane proteins, which are crucial for helping cells communicate and transport substances. By using techniques like X-ray crystallography and advanced microscopy, the lab investigates how these proteins work, particularly in bacteria. The research has important implications for drug development and understanding how bacteria adapt to their environments.

David D Ginty's lab focuses on understanding how our sense of touch works, including how our body and brain process different types of tactile stimuli like pressure and texture. They explore the biology of sensory neurons in the skin and how these neurons develop and function in both healthy and disease conditions. By using advanced techniques and mouse models, the lab aims to uncover the underlying mechanisms of touch sensation and train the next generation of neuroscientists.

Dr. Michael Eldon Greenberg's lab at Harvard Medical School investigates how sensory experiences influence the development of neural circuits, particularly in the visual system. His research focuses on the role of a specific type of brain cell called astrocytes in regulating visual plasticity and the molecular mechanisms tied to learning and memory. By understanding these processes, the lab aims to uncover new approaches to treat conditions such as amblyopia and other neurodevelopmental disorders.

Dr. Christophe O. Benoist's lab focuses on understanding how T regulatory cells (Tregs) in the gut are maintained and shaped by the microbiome and food antigens. The lab investigates the role of Tregs in preventing inflammation and autoimmunity, particularly in the context of the IPEX syndrome, a condition related to faulty Treg function. Through a combination of advanced genetic techniques and single-cell analysis, the lab seeks to map the pathways that define Treg behavior and how they interact with their environment.

Dr. Ya-Chieh Hsu's research lab at Harvard University focuses on understanding how stem cells age, particularly hair follicle stem cells (HFSCs). The lab studies the loss of regenerative capacity in aging stem cells and seeks to identify genes that could rejuvenate these cells. By employing advanced genetic techniques and innovative methods, the team aims to uncover the cellular changes that occur as HFSCs age, with hopes of developing therapies to combat age-related declines in stem cell function.

Dr. Rita Hamad's lab focuses on understanding how county-level policies during the COVID-19 pandemic have impacted mental health and healthcare access, particularly for vulnerable communities. By analyzing data from across the U.S., her research aims to identify which policies have helped or worsened existing disparities in mental health outcomes. The findings are intended to inform future public health policy and intervention efforts.

Dr. Christopher D. Harvey's lab at Harvard Medical School focuses on understanding how the brain processes spatial navigation and decision-making, critical functions that can be impaired in diseases like Alzheimer's. The lab investigates the posterior parietal cortex (PPC), a brain region involved in these processes, by exploring its connectivity, the roles of different neuron types, and how these elements change during learning. This research aims to provide insights into the neuronal mechanisms that underpin cognitive functions and their disruptions in neurodegenerative conditions.

Dr. Sophie Helaine's research focuses on understanding how certain bacteria, like Salmonella, survive stressful conditions and become resistant to antibiotics. The lab studies specialized genes called Toxin-Antitoxin systems that help bacteria control their growth in response to threats from the immune system or antibiotics. By exploring how these systems are activated and how they function, the lab aims to uncover new strategies to combat antibiotic resistance and improve treatment for bacterial infections.

Dr. Michael David Hughes leads a research lab at Harvard School of Public Health focused on advanced statistical methodologies and data management to improve clinical trials for HIV/AIDS and associated infections. The lab supports the AIDS Clinical Trials Group, which aims to develop novel interventions, enhance treatment strategies, and improve diagnostic approaches for individuals living with HIV and co-infections like tuberculosis and hepatitis B. Their work is critical in shaping international research standards and treatment protocols that ultimately enhance public health outcomes.

Dr. Terence D Capellini's lab at Harvard University focuses on studying the genes that determine the unique features of the human skeleton compared to other mammals, particularly mice. By examining the human fetal skeleton, the lab uses advanced genomic techniques to find causal genetic variants linked to skeletal diseases. Their work aims to enhance our understanding of musculoskeletal development, which can lead to better insights into conditions like hip dysplasia and osteoarthritis.

Dr. Bruce P. Bean's lab focuses on understanding how different types of ion channels in neurons work together to control how neurons fire. By studying the interactions between various channels, such as sodium, calcium, and potassium, the lab aims to design new drugs that can precisely target specific types of neurons involved in pain and epilepsy. This pioneering research could lead to more effective treatments for these conditions.

Ruaidhri Jackson's lab at Harvard Medical School focuses on uncovering the hidden complexities of the immune system's genome. The team is investigating non-coding RNAs and novel protein-coding mechanisms that play crucial roles in the inflammatory response. By using advanced techniques like ribosome profiling, they aim to redefine our understanding of gene function and discover new therapeutic targets for diseases related to immune response.

Dr. Dennis L. Kasper's lab at Harvard Medical School investigates how the gut's immune system, particularly a part called the complement system, protects against infections. They focus on how this system works locally in the gut rather than relying just on the blood. Recent findings show that a protein called C3, produced in the gut, plays a crucial role in fighting off pathogens such as bacteria that cause diarrhea. The lab aims to understand how the gut microbiome influences C3 levels and explore new therapeutic strategies for combating infectious diseases.

Dr. Scott G. Kennedy's lab at Harvard Medical School focuses on understanding the role of non-coding RNAs in gene regulation and inheritance. The research primarily uses the C. elegans model to investigate how these molecules influence gene expression and contribute to the transmission of epigenetic information across generations. This work aims to uncover the mechanisms behind epigenetic processes that could be linked to various human diseases.